Bioventus
BVS
BVS
66 hedge funds and large institutions have $92.6M invested in Bioventus in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 32 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
7% less funds holding
Funds holding: 71 → 66 (-5)
25% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 20
59% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 32
Holders
66
Holding in Top 10
2
Calls
$738K
Puts
$72K
Top Buyers
| 1 | +$5.96M | |
| 2 | +$2.67M | |
| 3 | +$1.48M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$1.28M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$1.18M |
Top Sellers
| 1 | -$4.25M | |
| 2 | -$2.34M | |
| 3 | -$1.24M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$855K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$590K |